Hiroyuki Shimada

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Nobuko Hijiya, Alexey A Maschan, Carmelo Rizzari, Hiroyuki Shimada, Carlo Dufour, Hiroaki Goto, Hyoung Jin Kang, Terri Guinipero, Zeynep Karakas, Francisco J Bautista Sirvent, Stéphane Ducassou, Keon Hee Yoo, Christian Michel Zwaan, Frédéric Millot, Briana Patterson, Jill H Samis, Miguel Izquierdo, Ksenia Titorenko, Sai Li, Darintr Sosothikul
The Long-term Efficacy and Safety of Nilotinib in Pediatric Patients With CML: a 5-Year Update of the DIALOG Study. Blood advances (2023)
Haruko Shima, Akiko Kada, Akihiko Tanizawa, Iori Sato, Chikako Tono, Masaki Ito, Yuki Yuza, Akihiro Watanabe, Kiyoko Kamibeppu, Hideko Uryu, Katsuyoshi Koh, Chihaya Imai, Nao Yoshida, Yuhki Koga, Naoto Fujita, Akiko M Saito, Souichi Adachi, Eiichi Ishii, Hiroyuki Shimada
Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia. Pediatric blood & cancer 69 (8) (2022)
Nobuko Hijiya, Alexey A Maschan, Carmelo Rizzari, Hiroyuki Shimada, Carlo Dufour, Hiroaki Goto, Hyoung Jin Kang, Terri Guinipero, Zeynep Karakas, Francisco Bautista, Stéphane Ducassou, Keon Hee Yoo, Christian Michel Zwaan, Frédéric Millot, Briana Patterson, Jill H Samis, Paola Aimone, Alex Allepuz, Ksenia Titorenko, Darintr Sosothikul
A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety. Blood advances 5 (14) (2021)

Hiroyuki Shimada.css-eqlu8i{font-size:small;padding-left:4px;}